The firm prefers to invest in companies that bring human medicines or medical devices to the market, and it seeks to take an active role in financing and other strategic events. Excalibur Fund Managers likes to play a leading role in its portfolio companies by taking a seat on the board of directors. The firm was founded in 1996 and is based in London, United Kingdom, operating as a subsidiary of Excalibur Group Holdings Ltd. The latter is a venture capital firm that primarily invests in the biotechnology, healthcare, and life science sectors, acting as a link between research, development, production, commercialization, supply and distribution of drugs, devices, diagnostics and facilities with individual and institutional investors, equity and debt markets, start-up and expansion capital, strategic advice, and ultimately trade sale or flotation.